$FF

FutureFuel Corp. (FF): Results of Operations and Financial Condition

FutureFuel Corp. (FF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FUTUREFUEL ANNOUNCES SECOND QUARTER 2026 RESULTS BATESVILLE, Ark., August 10, 2026 – FutureFuel Corp . (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarte

Original reporting
Published Aug 10, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$FF
Bullish
medium confidence
Mentioned
$FF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FFBullishMed
01

Why it matters

The filing provides both backward-looking performance metrics (revenue, gross profit, net income, Adjusted EBITDA) and forward-looking cash/earnings signals (full-year positive Adjusted EBITDA expectation and a quantified Section 45Z credit monetization cash schedule).

02

Market read

Traders can update expectations for FutureFuel’s earnings power and liquidity trajectory based on the Q2 profitability rebound and the stated full-year Adjusted EBITDA outlook, while monitoring the extent to which results depend on hedging and inventory/derivative effects.

03

What to watch

Adjusted EBITDA excludes certain non-cash derivative timing differences and the company notes it cannot fully reconcile full-year Adjusted EBITDA, increasing uncertainty around comparability and sustainability.

Relevance 7/10Novelty 7/10Timing: filed after market close, for next-session repricing
alphai · Earnings readFF · Second Quarter 2026 · ended June 30, 2026

FutureFuel Announces Second Quarter 2026 Results

Strong quarter

Revenue increased 120.7%, the Company reported net income of $11.4 million versus a net loss of ($14.2) million, and both Chemicals and Biofuels reported positive gross profit. The release also identifies significant derivative-related benefits and continued elevated input costs.

Revenue
$78.7 million
120.7% y/y
Chemicals
$25.8 million
55.5% y/y
EPS · GAAP
$0.25

Key metrics

as reported
MetricValueq/qy/y
Total revenueGAAP$78.7 million120.7%
Total volume growthother40.4%
Average blended price increaseother80.2%
Total gross profitGAAP$15.0 million
Net incomeGAAP$11.4 million+$25.6 million
Diluted earnings per shareGAAP$0.25 per diluted share
Adjusted EBITDAnon-GAAP$11.8 million+$23.2 million
Chemicals gross profitGAAP$5.0 million
Chemicals capacity utilizationother65%
Biofuels gross profitGAAP$10.1 million
Biofuels capacity utilizationother56%
Net cash flow from operationsGAAP$18.8 million

Segments

SegmentRevenueq/qy/y
ChemicalsThe increase was primarily driven by a 49% increase in volume/product mix effects and a 6% benefit from higher average prices.$25.8 million55.5%
Custom ChemicalHigher volumes of products sold to energy customers.$18.5 million30%
Performance ChemicalIncreased volumes for a new customer that began production during the fourth quarter of 2025.$7.3 million209%
BiofuelsIncreased regulatory clarity surrounding the Clean Fuel Production Credit and record-high renewable volume obligation levels.$52.9 million178%

Full-year 2026 outlook

  • NoteAnticipate positive Adjusted EBITDA in full-year 2026, excluding non-cash derivative timing differences related to changes in physical commodity prices.
  • NoteThird quarter production rates are expected to exceed second quarter levels.
  • NoteDuring the second half of 2026, the Company expects to receive $22 million in gross proceeds from the monetization of credits, including approximately $3 million in the third quarter and $19 million in the fourth quarter.
  • NoteSales volumes are expected to further improve during the second half of 2026 given improved regulatory clarity.
  • NoteInput costs for soybean oil and other raw materials used in the production of biofuels remain elevated, which is expected to have a continued, near-term impact on Biofuels gross profit per gallon sold.

What drove it

  • Higher throughputs, an improved revenue mix, and higher average pricing in both the Chemical and Biofuel segments drove total revenue growth.
  • Total production increased 26% on a year-over-year basis.
  • Chemicals production increased 34% year-over-year, supported by demand across energy and industrial end-markets.
  • Biofuels production increased 21% year-over-year despite a more than three-week biodiesel plant outage.
  • The Company increased total Chemicals production capacity by 12% during the last twelve months.
  • Second-quarter gross profit included $9.1 million related to the sale of physical inventory at prices above hedged levels and unrealized derivative gains of $3.2 million.

Concerns

  • Second-quarter gross profit benefited from $9.1 million related to physical inventory sold at prices above hedged levels and $3.2 million of unrealized derivative gains.
  • The Company stated that elevated input costs have partially offset the favorable pricing environment for finished Biofuels products and are expected to continue to affect Biofuels gross profit per gallon sold in the near term.
  • Biofuels experienced a more than three-week biodiesel plant outage during the quarter.
  • The management-commentary summary says Chemicals gross profit was $5.0 million versus $1.1 (3) million in the year-ago period, while the Chemicals segment section reports $5.0 million versus $3.8 million.

What to watch

  • Whether third-quarter Biodiesel production rates exceed second-quarter levels.
  • Whether Biofuels sales volumes improve during the second half of 2026 as regulatory clarity improves.
  • The receipt of approximately $3 million in third-quarter and $19 million in fourth-quarter gross proceeds from monetization of credits.
  • The effect of elevated soybean oil and other raw-material costs on Biofuels gross profit per gallon sold.
  • Whether increased Chemicals capacity and 65% capacity utilization produce further operating leverage.

Balance sheet and cash flow

  • Total cash and equivalents of $34.3 million as of June 30, 2026, up from $22.4 million at March 31, 2026.
  • $35 million revolving credit facility with no outstanding borrowings.
  • Net cash flow from operations was $18.8 million in the second quarter of 2026, compared to $5.2 million in the prior-year period.
  • The Company secured a four-year agreement with a third-party to monetize Section 45Z Clean Fuel Production and Small Producer Tax Credits.
  • The Company expects to receive $22 million in gross proceeds from the monetization of credits during the second half of 2026, including approximately $3 million in the third quarter and $19 million in the fourth quarter.

Analysis

FutureFuel reported a substantial second-quarter turnaround. Total revenue was $78.7 million, up 120.7% from $35.7 million, while total gross profit was $15.0 million versus a gross loss of ($12.4) million. The Company reported net income of $11.4 million, compared with a net loss of ($14.2) million, and Adjusted EBITDA of $11.8 million compared with ($11.4) million. Management attributed the revenue increase to higher throughputs, improved mix, and higher average pricing in both operating segments.

Chemicals revenue increased to $25.8 million, with Custom Chemical revenue of $18.5 million and Performance Chemical revenue of $7.3 million. Demand from energy customers and volumes from a customer that began production in the fourth quarter of 2025 were the stated contributors. Chemicals capacity utilization improved to 65% from 54%, and the Company said total Chemicals production capacity increased by 12% during the last twelve months. The detailed segment discussion reported Chemicals gross profit of $5.0 million versus $3.8 million.

Biofuels revenue increased to $52.9 million from $19.1 million, and gross profit was $10.1 million versus a gross loss of ($13.5) million. Management cited regulatory clarity surrounding the Clean Fuel Production Credit and record-high renewable volume obligation levels, along with higher sales volumes and pricing realization. Biofuels production increased 21% year-over-year despite a more than three-week biodiesel plant outage, and capacity utilization reached 56%. Elevated soybean oil and other input costs remain a stated near-term constraint on Biofuels gross profit per gallon sold.

Profitability also reflected material hedging and derivative effects. Second-quarter gross profit benefited by $9.1 million from physical inventory sold at prices above hedged levels, which the Company said fully offset realized derivative losses of ($9.1) million recognized in the first quarter of 2026. Gross profit also benefited from unrealized derivative gains of $3.2 million. Management explicitly characterized the full-year Adjusted EBITDA objective as excluding non-cash derivative timing differences related to physical commodity-price changes.

Liquidity increased during the quarter. The financial-resources section reported total cash and equivalents of $34.3 million at June 30, 2026, compared with $22.4 million at March 31, 2026, alongside a $35 million revolving credit facility with no outstanding borrowings. Net cash flow from operations was $18.8 million versus $5.2 million in the prior-year period. The Company expects $22 million in gross proceeds from credit monetization during the second half of 2026 and continues to anticipate positive Adjusted EBITDA for full-year 2026, but it provided no quantitative revenue, margin, expense, or tax-rate outlook.

Management, verbatim

The second quarter marked a return to profitable growth for FutureFuel, a performance driven by strengthening end-market demand, improved production economics, continued cost discipline, and enhanced optimization of our Batesville plant.

Roeland Polet, Chairman and Chief Executive Officer of FutureFuel

While our second quarter results include a timing benefit related to ongoing biofuels hedging activity, our core business performed well in the period, delivering its strongest financial performance since the fourth quarter of 2024.

Roeland Polet, Chairman and Chief Executive Officer of FutureFuel

During the second half of 2026, we expect to receive $22 million in gross proceeds from the monetization of credits, including approximately $3 million in the third quarter and $19 million in the fourth quarter.

Rose Sparks, Chief Financial Officer

Not in the filing

stated, not guessed
  • GAAP operating income and prior-year comparison were not provided in the supplied text.
  • GAAP operating margin and gross margin were not provided in the supplied text.
  • Non-GAAP earnings per share was not provided in the supplied text.
  • Prior-year diluted earnings per share was not provided in the supplied text.
  • Free cash flow was not provided in the supplied text.
  • Capital-return activity, including share repurchases and dividends, was not provided in the supplied text.
  • Debt balance other than no outstanding borrowings on the revolving credit facility was not provided in the supplied text.
  • Capital-expenditure period comparison was not available because the supplied filing text is truncated after the beginning of the capital-expenditures sentence.
  • Quantitative full-year revenue, gross-margin, operating-expense, and tax-rate guidance were not provided.
  • Previous-quarter outlook was not provided.
  • The CFO commentary states total cash of $34.4 million at the end of the second quarter, while the financial-resources section states total cash and equivalents of $34.3 million as of June 30, 2026.

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC 8-K (Item 2.02) with Exhibit 99.1 announcing FutureFuel’s second quarter and six months ended June 30, 2026 financial results.

Company-level read

Ticker impact

$FFBullishMedium confidence
Context

FutureFuel reported Q2 2026 results with total revenues up 120.6% and GAAP net income of $11.4 million, plus a full-year positive Adjusted EBITDA outlook.

Expected impact

Likely positive bias for near-term trading as the filing shows a return to profitability and liquidity improvement, though investors may discount for commodity-hedge timing and non-GAAP adjustments.

Evidence & confidence

The 8-K includes concrete financial datapoints (revenue, net income, Adjusted EBITDA) and forward-looking expectations for full-year Adjusted EBITDA, plus a quantified credit monetization cash schedule.

Market effects

Biofuels and specialty chemicals producers may see read-across interest if regulatory clarity and production incentives are supporting margins and throughput.

Batesville, Arkansas plant optimization and outage recovery could influence local sentiment but is unlikely to move broader regional markets.

Limited global spillover; story is company-specific within US biofuels and specialty chemicals.

Counterpoint

The headline profitability improvement is partly driven by derivative timing and physical inventory sales above hedged levels, which may not repeat each quarter.

Key entities

  • FutureFuel Corp.

    Manufacturer of custom and performance chemicals and biofuels; reported Q2 2026 results and provided full-year Adjusted EBITDA expectations.

  • Roeland Polet

    Chairman and CEO who commented on demand, production economics, and full-year outlook.

  • Rose Sparks

    CFO who discussed cash flow and the Section 45Z credit monetization agreement and expected proceeds.

Every FF earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$FFMedAI 8/10

Biofuel Stock FutureFuel Corp. (NYSE: FF) Soars on Strong Second Quarter

FutureFuel Corp. (NYSE: FF) shares rose after it reported Q2 2026 results. The company said total revenue was $78.7 million, up 120.6% year over year, with GAAP net income of $11.4 million ($0.25 diluted) and adjusted EBITDA of $11.8 million. It also cited higher chemicals and biofuel revenue, improved production, and expects positive full-year 2026 adjusted EBITDA.

$FFMedAI 8/10

Why is FutureFuel stock surging today?

Investing.com reports FutureFuel Corp. shares rose 21.5% in pre-open trading after its Q2 2026 results. The company posted $78.7M revenue, up over 120% year over year, GAAP net income of $11.4M ($0.25/diluted share), and Adjusted EBITDA of $11.8M versus a $14.2M net loss in Q2 2025. Management cited stronger Chemicals demand and improved Biofuels regulation, reaffirming full-year 2026 guidance.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.